Free Trial

Synopsys (SNPS) Stock Forecast & Price Target

Synopsys logo
$492.18 -1.17 (-0.24%)
(As of 12/20/2024 05:51 PM ET)

Synopsys - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
9

Based on 10 Wall Street analysts who have issued ratings for Synopsys in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 1 has given a hold rating, and 9 have given a buy rating for SNPS.

Consensus Price Target

$649.00
31.86% Upside
According to the 10 analysts' twelve-month price targets for Synopsys, the average price target is $649.00. The highest price target for SNPS is $690.00, while the lowest price target for SNPS is $570.00. The average price target represents a forecasted upside of 31.86% from the current price of $492.18.
Get the Latest News and Ratings for SNPS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Synopsys and its competitors.

Sign Up

SNPS Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
9 Buy rating(s)
11 Buy rating(s)
10 Buy rating(s)
10 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$649.00$649.82$630.09$576.60
Forecasted Upside31.86% Upside16.51% Upside24.36% Upside9.94% Upside
Consensus Rating
Moderate Buy
Buy
Buy
Buy

SNPS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SNPS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Synopsys Stock vs. The Competition

TypeSynopsysComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.90
2.68
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside31.86% Upside264.23% Upside14.54% Upside
News Sentiment Rating
Positive News

See Recent SNPS News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/6/2024Piper Sandler
2 of 5 stars
 Lower TargetOverweight ➝ Overweight$670.00 ➝ $655.00+27.11%
12/5/2024Robert W. Baird
2 of 5 stars
 Lower TargetOutperform ➝ Outperform$644.00 ➝ $630.00+7.14%
12/5/2024Needham & Company LLC
2 of 5 stars
 Reiterated RatingBuy ➝ Buy$640.00 ➝ $640.00+8.84%
12/4/2024Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$635.00 ➝ $635.00+11.37%
11/22/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Mobley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$570.00+2.20%
11/11/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Mobley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$675.00+21.35%
10/22/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Panigrahi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$650.00+28.56%
10/15/2024Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Naing
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$660.00+21.00%
8/22/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$655.00 ➝ $685.00+21.10%
6/27/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$675.00 ➝ $690.00+15.28%
11/27/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$550.00+0.92%
11/10/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$600.00+17.88%
10/10/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$510.00 ➝ $600.00+24.02%
9/29/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$551.00+19.60%
1/17/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:15 AM ET.


Should I Buy Synopsys Stock? SNPS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 13, 2024. Please send any questions or comments about these Synopsys pros and cons to contact@marketbeat.com.

Synopsys
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Synopsys, Inc.:

  • Recent analyst ratings have been overwhelmingly positive, with ten analysts issuing a buy rating, indicating strong confidence in the company's future performance.
  • The average target price set by analysts is $650.50, suggesting significant upside potential from the current stock price of $515.29.
  • Synopsys, Inc. operates in a growing sector of electronic design automation, which is crucial for the development of integrated circuits, positioning the company well for future demand.
  • The company has a solid market capitalization of $79.15 billion, reflecting its stability and ability to invest in innovation and growth.
  • With a price-to-earnings ratio of 53.45, while high, it indicates that investors are willing to pay a premium for the company's earnings, often a sign of strong growth expectations.

Synopsys
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Synopsys, Inc. for these reasons:

  • The stock has experienced significant volatility, recently trading down $72.71, which may indicate underlying instability or market concerns.
  • With a PEG ratio of 3.48, the stock may be considered overvalued relative to its growth rate, suggesting that future growth may not justify the current price.
  • Wells Fargo & Company issued an "equal weight" rating with a lower price objective of $570.00, indicating a more cautious outlook compared to other analysts.
  • The company has a relatively high beta of 1.08, suggesting that its stock price is more volatile than the market, which could pose risks for conservative investors.
  • Despite a strong consensus rating of "Moderate Buy," the presence of a hold rating from one analyst may indicate some uncertainty about the stock's near-term performance.

SNPS Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Synopsys is $649.00, with a high forecast of $690.00 and a low forecast of $570.00.

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last twelve months. There is currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SNPS shares.

According to analysts, Synopsys's stock has a predicted upside of 31.86% based on their 12-month stock forecasts.

Synopsys has been rated by research analysts at Berenberg Bank, Loop Capital, Mizuho, Needham & Company LLC, Piper Sandler, Robert W. Baird, Rosenblatt Securities, and Wells Fargo & Company in the past 90 days.

Analysts like Synopsys more than other "computer and technology" companies. The consensus rating score for Synopsys is 2.90 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how SNPS compares to other companies.


This page (NASDAQ:SNPS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners